Loading...
HSChapter 30
U.S. imports of non-penicillin antibiotics in dosage form (nesoi) (HS 300420) totaled $112.2M in April 2026, traded with 27 countries.
Non-Penicillin Antibiotics in Dosage Form (NESOI) imports of $112.2M in April 2026 ran 12% below the year-to-date monthly average of $127.9M.
Last updated: April 2026 dataFinished-dose antibiotics outside the penicillin/streptomycin family — including macrolides (azithromycin, erythromycin), tetracyclines (doxycycline, tetracycline), lincosamides (clindamycin), cephalosporins (cefdinir, cefepime, ceftazidime), carbapenems (meropenem), and glycopeptides (vancomycin) — are each assigned dedicated 10-digit tariff lines, making this one of the most granularly subdivided pharmaceutical headings in the US schedule. India leads supply, followed by Italy, China, Switzerland, and Portugal. The breadth of named drug lines reflects both the commercial scale of these generics and heightened regulatory interest in tracking hospital-critical antibiotics. Importers should note that several molecules in this heading, particularly carbapenems and vancomycin, are considered last-resort antibiotics subject to close FDA scrutiny for manufacturing quality.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Classification of combination antibiotic products depends on which antibiotic is considered the essential character or is specifically named in a tariff line. Heading 300410 covers combinations containing penicillins, while 300420 covers other antibiotics. If a combination contains a penicillin alongside another antibiotic class, it will generally fall under 300410 unless a specific line in 300420 more precisely describes it. A binding ruling from CBP is advisable for novel combinations.
Certain finished pharmaceutical products, including some antibiotic dosage forms, have been subject to Section 301 tariffs when imported from China. Importers should verify the current Section 301 status for the specific 10-digit HTS line applicable to their product, as exclusions and modifications have changed over time. A licensed customs broker can confirm current applicability.
Monthly import values over time
Supplier Network
Get discovered by U.S. importers searching for HS 300420 — Non-Penicillin Antibiotics in Dosage Form (NESOI). Be the first supplier listed.
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % |
|---|---|---|---|
| 3004200083 | MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI | $64.0M | -- |
| 3004200010 | MEDICAMENTS CONT ANTIBIOTICS NESOI, VET USE | $17.0M | -- |
| 3004200080 | MEDS CONT OTHER ANTIBIOTICS, CONTAINING VANCOMYCIN | $6.1M | -- |
| 3004200076 | MEDS CONT OTHER ANTIBIOTICS, CONTAINING MEROPENUM | $5.6M | -- |
| 3004200055 | MEDS CONT OTHR ANTIBTCS,CONT CLINDAMYCIN,ITS SALTS | $4.3M | -- |
| 3004200030 | TETRACYCLINE, SINGLES OR IN COMB ETC NOT FOR VET | $4.2M | -- |
| 3004200020 | ERYTHROMYCIN, SINGLES OR IN COMB ETC NOT FOR VET | $3.1M | -- |
| 3004200065 | MEDS CONT OTH ANTIBTCS,CONT DOXYCYCLINE, ITS SALTS | $2.7M | -- |
| 3004200071 | MEDS CONT OTHER ANTIBIOTICS, CONTAINING CEFEPIME | $2.7M | -- |
| 3004200045 | MEDS CONT OTH ANTIBTCS,CONT AZITHROMYCIN,ITS SALTS | $1.2M | -- |
| 3004200070 | MEDS CONT OTHER ANTIBIOTICS, CONTAINING CEFDINIR | $784K | -- |
| 3004200072 | MEDS CONT OTHER ANTIBIOTICS,CONTAINING CEFTAZIDIME | $372K | -- |
| 3004200075 | MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI | $0 | -- |
MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI
MEDICAMENTS CONT ANTIBIOTICS NESOI, VET USE
MEDS CONT OTHER ANTIBIOTICS, CONTAINING VANCOMYCIN
MEDS CONT OTHER ANTIBIOTICS, CONTAINING MEROPENUM
MEDS CONT OTHR ANTIBTCS,CONT CLINDAMYCIN,ITS SALTS
TETRACYCLINE, SINGLES OR IN COMB ETC NOT FOR VET
ERYTHROMYCIN, SINGLES OR IN COMB ETC NOT FOR VET
MEDS CONT OTH ANTIBTCS,CONT DOXYCYCLINE, ITS SALTS
MEDS CONT OTHER ANTIBIOTICS, CONTAINING CEFEPIME
MEDS CONT OTH ANTIBTCS,CONT AZITHROMYCIN,ITS SALTS
MEDS CONT OTHER ANTIBIOTICS, CONTAINING CEFDINIR
MEDS CONT OTHER ANTIBIOTICS,CONTAINING CEFTAZIDIME
MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004200060 | MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI | $44.3M |
| 3004200010 | MEDICAMENTS CONT ANTIBIOTICS NESOI, VET USE | $7.0M |
| 3004200020 | ERYTHROMYCIN, SINGLES OR IN COMB ETC NOT FOR VET | $49K |
| 3004200030 | TETRACYCLINE, SINGLES OR IN COMB ETC NOT FOR VET | $4K |
MEDICAMENTS CONTAINING OTHER ANTIBIOTICS, NESOI
60.8K kg
MEDICAMENTS CONT ANTIBIOTICS NESOI, VET USE
147.2K kg
ERYTHROMYCIN, SINGLES OR IN COMB ETC NOT FOR VET
82 kg
TETRACYCLINE, SINGLES OR IN COMB ETC NOT FOR VET
1 kg
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| California | $1.4M | $17.2M | +$15.8M |
| Indiana | $13.7M | $4.8M | -$8.9M |
| New Jersey | $15.5M | $636K | -$14.9M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| NEWARK, NJ | $22.6M | $1.2M | -$21.4M |
| CHICAGO, IL | $11.6M | $10.1M | -$1.5M |
| LOS ANGELES INTERNATIONAL AIRPORT, CA | $742K | $17.2M | +$16.5M |